How health and motivation change during the 13-week KHEOPS physical activity program for women treated for breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational study following women enrolled in the 13-week KHEOPS adapted physical activity (APA) program at Centre Léon Bérard. Participants complete two short online questionnaires each week and attend KHEOPS sessions either in person or remotely while clinical and motivational constructs derived from M‑PAC are recorded over time. Secondary aims include measuring the feasibility of the psychological measures and program participation, tracking cancer-related psychological symptoms, and relating changes in psychological factors to adherence and post-program physical activity levels. The study focuses on women undergoing or after surgery for non-metastatic breast cancer who can use a smartphone, tablet, or computer and read French.

Why it matters

Who can join: the full rules

Inclusion Criteria

* Woman aged ≥ 18 years
* Diagnosed with non-metastatic breast cancer
* Undergoing treatment or after surgery
* Participating in the CLB KHEOPS program, either face-to-face or distance learning
* Have a smartphone, computer or tablet to answer the 2 weekly online weekly online questionnaires and to follow APA sessions for patients following the patients following the KHEOPS program remotely
* Having received a study information note and having made a declaration of non-opposition
* Affiliated with a social security scheme
* Able to read, write and understand French

Exclusion Criteria:

* Unable to be followed for medical, social, family, geographical or psychological reasons, for the duration of the study.
* Have difficulty completing a questionnaire alone
* Deprived of liberty by judicial or administrative decision, or adults protected by law
* Concurrently participating in another PA study

Where it's running

• Centre Léon Bérard
  Lyon, France Recruiting

Study contacts

• Principal investigator: Béatrice Fervers, Pr — Département Prévention Cancer Environnement, Centre Léon Bérard
• Study coordinator: Carmen Dupuis, PhD
• Email: carmen.dupuisl@lyon.unicancer.fr
• Phone: 0469856218

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.